National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- (-) Cancer (29)
- Cancer: Breast Cancer (4)
- Cancer: Colorectal Cancer (4)
- Cancer: Lung Cancer (3)
- Cancer: Ovarian Cancer (1)
- Cancer: Prostate Cancer (3)
- Cancer: Skin Cancer (2)
- Cardiovascular Conditions (2)
- Care Coordination (1)
- Case Study (1)
- Clinical Decision Support (CDS) (2)
- Colonoscopy (1)
- Comparative Effectiveness (1)
- COVID-19 (1)
- Decision Making (1)
- Diagnostic Safety and Quality (1)
- Evidence-Based Practice (18)
- Family Health and History (1)
- Genetics (3)
- (-) Guidelines (29)
- Healthcare Delivery (4)
- Health Information Technology (HIT) (2)
- Hospitals (1)
- Imaging (2)
- Implementation (1)
- Medicare (2)
- Medication (1)
- Men's Health (1)
- Organizational Change (1)
- Palliative Care (1)
- Patient-Centered Outcomes Research (3)
- Practice Patterns (4)
- Prevention (12)
- Primary Care (2)
- Quality Measures (1)
- Racial and Ethnic Minorities (1)
- Risk (1)
- Screening (12)
- Surgery (3)
- U.S. Preventive Services Task Force (USPSTF) (11)
- Women (5)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
26 to 29 of 29 Research Studies DisplayedKrell RW, Reames BN, Hendren S
Surgical referral for colorectal liver metastases: a population-based survey.
The researchers sought to understand medical oncologists’ perspectives on referral for colorectal liver metastases (CLM). They found wide variation in surgical referral patterns for CLM. Many felt that bilobar disease and tumor size were contraindications to liver-directed therapy despite a lack of supporting data.
AHRQ-funded; HS020937.
Citation: Krell RW, Reames BN, Hendren S .
Surgical referral for colorectal liver metastases: a population-based survey.
Ann Surg Oncol 2015 Jul;22(7):2179-94. doi: 10.1245/s10434-014-4318-x..
Keywords: Cancer, Surgery, Guidelines, Practice Patterns
Dinan MA, Mi X, Reed SD
Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the Medicare population, 2005-2009.
The researchers examined trends in the use of the 21-gene recurrence score (RS) assay in routine clinical practice in a nationally representative sample of women with breast cancer. They found that the RS assay was adopted quickly in clinical practice after the Medicare coverage decision in 2006, and use appears to be consistent with guidelines and equitable across geographic and racial groups.
AHRQ-funded; HS022189.
Citation: Dinan MA, Mi X, Reed SD .
Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the Medicare population, 2005-2009.
JAMA Oncol 2015 May;1(2):158-66. doi: 10.1001/jamaoncol.2015.43..
Keywords: Cancer, Cancer: Breast Cancer, Genetics, Guidelines, Medicare, Practice Patterns, Women
Silver MI, Rositch AF, Burke AE
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
The purpose of this study was to explore attitudes toward new cervical cancer screening options and understand factors associated with those beliefs among women in routine gynecologic care. It found that the majority still believed women should be screened every year. Despite this, two-thirds stated that they would be willing to extend screening to every 3 years if their doctor recommended it.
AHRQ-funded; HS022199.
Citation: Silver MI, Rositch AF, Burke AE .
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Obstet Gynecol 2015 Feb;125(2):317-29. doi: 10.1097/aog.0000000000000638..
Keywords: Screening, Guidelines, Cancer, Women
Nelson HD, Pappas M, Zakher B
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
This systematic review was done in support of the U.S. Preventive Services Task Force (USPSTF) updated recommendation on the benefit and harms of risk assessment, genetic testing, and genetic counseling for BRCA-related cancer in women. A systematic review was done on literature from 2004 to July 30, 2013 from MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Health Technology Assessment, Scopus, and reference lists. Data on the participants, study design, analysis, follow-up, and results was extracted and a second investigator confirmed key data. The studies were rated on study quality and applicability. The analysis found women with high-risk for breast cancer had decreased risk of breast cancer by 85% to 100% by having a mastectomy, and risk of mortality by 81% to 100% compared to women without surgery. There was also a lower risk of breast and ovarian cancer after having salpingo-oopherectomy surgery.
AHRQ-funded; 290200710057
Citation: Nelson HD, Pappas M, Zakher B .
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Ann Intern Med 2014 Feb 18;160(4):255-66. doi: 10.7326/m13-1684..
Keywords: U.S. Preventive Services Task Force (USPSTF), Cancer: Breast Cancer, Cancer: Ovarian Cancer, Cancer, Genetics, Screening, Prevention, Guidelines, Evidence-Based Practice, Women, Risk, Family Health and History